Cite
Ow TJ, Fulcher CD, Thomas C, et al. Optimal targeting of BCL-family proteins in head and neck squamous cell carcinoma requires inhibition of both BCL-xL and MCL-1. Oncotarget. 2019;10(4):494-510doi: 10.18632/oncotarget.26563.
Ow, T. J., Fulcher, C. D., Thomas, C., Broin, P. �. �., López, A., Reyna, D. E., Smith, R. V., Sarta, C., Prystowsky, M. B., Schlecht, N. F., Schiff, B. A., Rosenblatt, G., Belbin, T. J., Harris, T. M., Childs, G. C., Kawachi, N., Guha, C., & Gavathiotis, E. (2019). Optimal targeting of BCL-family proteins in head and neck squamous cell carcinoma requires inhibition of both BCL-xL and MCL-1. Oncotarget, 10(4), 494-510. https://doi.org/10.18632/oncotarget.26563
Ow, Thomas J, et al. "Optimal targeting of BCL-family proteins in head and neck squamous cell carcinoma requires inhibition of both BCL-xL and MCL-1." Oncotarget vol. 10,4 (2019): 494-510. doi: https://doi.org/10.18632/oncotarget.26563
Ow TJ, Fulcher CD, Thomas C, Broin PÓ, López A, Reyna DE, Smith RV, Sarta C, Prystowsky MB, Schlecht NF, Schiff BA, Rosenblatt G, Belbin TJ, Harris TM, Childs GC, Kawachi N, Guha C, Gavathiotis E. Optimal targeting of BCL-family proteins in head and neck squamous cell carcinoma requires inhibition of both BCL-xL and MCL-1. Oncotarget. 2019 Jan 11;10(4):494-510. doi: 10.18632/oncotarget.26563. eCollection 2019 Jan 11. PMID: 30728900; PMCID: PMC6355180.
Copy
Download .nbib